2 minute read
Hoag Recruits National Experts to Lead Cancer Clinical Research and Melanoma Programs
Artistic renderings are subject to change
Third floor
8full-time physician offices 27
8
visiting physician offices new high-tech & high-touch exam rooms
Enhanced collaboration between physicians and staff on complex cases
Throughout the Cancer Center, the generous and compassionate spirit of George Hoag II—and his iconic Hawaiian shirts, a fixture in the memories of many Hoag staff—will continue to permeate its halls. Since 1952, Hoag has partnered with the community to deliver care unmatched by other institutions. Today, that partnership lives on, making it possible for Hoag to lead the way forward in delivering world-class, customized cancer care that considers the whole patient.
Hoag Family Cancer Institute Establishes Two New Endowed Chairs
Through Hoag’s endowed chair program, philanthropy continues to distinguish Hoag from other hospitals in the region. The leadership, high-caliber research and patient care of Hoag’s endowed chair holders not only attract patients from across the country and the world but also help retain and recruit other physician experts working to advance standards of care. Our immense gratitude for the visionary support of Hoag’s endowed chair donors continues to grow as the impact of the program brings the latest developments in medicine to our community.
The Hoag Hospital Foundation hosted an investiture ceremony to celebrate and honor newly appointed endowed chair holders Drs. Demeure and Ulaner as well as donors Otis Healy and James and Pamela Muzzy in fall 2022.
Michael J. Demeure, MD, MBA, FACS, FACE
Otis Healy Family Endowed Chair in Applied Genomics
Dr. Michael Demeure, program director of the Hoag Precision Medicine Program, leads Hoag’s Center for Applied Genomic Technologies where he works with a multidisciplinary team to advance genetic profiling and targeted cancer therapies. He is an internationally recognized expert in cancer surgery and research, specializing in endocrine, pancreatic and gastrointestinal cancers.
As part of Hoag’s Center for Applied Genomic Technologies, cancer patients at Hoag have access to: • comprehensive tumor profiling performed by clinical genomic scientist Sourat Darabi, PhD, MS • targeted therapies based on specific malignancies and genetic abnormalities • a highly personalized approach, often leading to alternative treatment options for patients who may have previously been told, “There’s nothing else we can do.” • GRAIL, an investigational multi-cancer early detection DNA test
To learn more about Dr. Demeure’s work and his appointment as an endowed chair holder, scan the QR code at right.
“We are incredibly grateful and appreciate the ongoing generous support of our donors. Whether the funds are used to recruit excellent doctors, support nursing and staff or to foster innovative programs and research, the result is that the Hoag Family Cancer Institute is amongst the best in the country. Our program is unique because we are able to provide resources to our oncologists that are generally not available even at many university medical centers, and we do it to help patients in our community.”
